Skip to main content
. 2020 Jun 26;20(3):161–169. doi: 10.1007/s40268-020-00312-5

Fig. 2.

Fig. 2

SARS-CoV-2 interaction with the ACE2 PD domain (6M17). The projected view displays the interacting residues at the interface site. SARS-CoV-2 severe acute respiratory syndrome coronavirus 2, ACE2 angiotensin-converting enzyme 2, PD peptidase domain